CRPC w/ Bone Metastases

Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program. January 11, 2019

Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future Perspectives. January 4, 2019

Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223. January 3, 2019

Reversibility of castration resistance status after Radium-223 dichloride treatment: Clinical evidence and Review of the literature. December 20, 2018

Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging. December 3, 2018

The Case Against the European Medicines Agency's Change to the Label for Radium-223 for the Treatment of Metastatic Castration-resistant Prostate Cancer November 23, 2018

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects October 15, 2018

Targeted Alpha Therapy, an Emerging Class of Cancer Agents - A Review September 21, 2018

Microscopic Imaging Pierces the “Black Box” of Cancer Bone Metastasis August 1, 2018

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial May 17, 2018

Radiation for Treatment of Painful Bone Metastases May 15, 2018

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases March 20, 2018

Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy March 20, 2018

Optimal usage of radium-223 in metastatic castration-resistant prostate cancer March 14, 2018

The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer March 14, 2018

Radium-223 international early access program: results from the Spanish subset March 14, 2018

Utility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223 March 14, 2018

Impact of treatment delay in Radium-223 therapy of metastatic castration-resistant prostate cancer patients March 12, 2018

Launch of Oncotype DX® AR-V7 Nucleus Detect™ Test Expands Offering to Prostate Cancer Patients - Predicting Treatment Response in Metastatic Disease February 26, 2018

Current approaches to incorporation of radium-223 in clinical practice January 9, 2018

Page 1 of 10

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

CRPC w/ Bone Metastases

Free Daily and Weekly newsletters offered by content of interest

Login